Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Discovering and improving novel peptide therapeutics.

McGregor DP.

Curr Opin Pharmacol. 2008 Oct;8(5):616-9. doi: 10.1016/j.coph.2008.06.002. Epub 2008 Jul 16. Review.

PMID:
18602024
[PubMed - indexed for MEDLINE]
2.

Anti-mesothelin antibodies and circulating mesothelin relate to the clinical state in ovarian cancer patients.

Hellstrom I, Friedman E, Verch T, Yang Y, Korach J, Jaffar J, Swisher E, Zhang B, Ben-Baruch G, Tan MC, Goedegebuure P, Hellstrom KE.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1520-6. doi: 10.1158/1055-9965.EPI-08-0039.

PMID:
18559570
[PubMed - indexed for MEDLINE]
Free Article
3.

Molecular targets and targeted therapies for malignant mesothelioma.

Palumbo C, Bei R, Procopio A, Modesti A.

Curr Med Chem. 2008;15(9):855-67. Review.

PMID:
18473795
[PubMed - indexed for MEDLINE]
4.

Intraperitoneal chemotherapy in ovarian cancer: an update.

Runowicz CD.

Cancer J. 2008 Jan-Feb;14(1):7-9. doi: 10.1097/PPO.0b013e318163c2e0. Review.

PMID:
18303475
[PubMed - indexed for MEDLINE]
5.

Architecture of the large membrane-bound mucins.

Desseyn JL, Tetaert D, Gouyer V.

Gene. 2008 Mar 15;410(2):215-22. doi: 10.1016/j.gene.2007.12.014. Epub 2007 Dec 28. Review.

PMID:
18242885
[PubMed - indexed for MEDLINE]
6.

Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.

Hassan R, Ebel W, Routhier EL, Patel R, Kline JB, Zhang J, Chao Q, Jacob S, Turchin H, Gibbs L, Phillips MD, Mudali S, Iacobuzio-Donahue C, Jaffee EM, Moreno M, Pastan I, Sass PM, Nicolaides NC, Grasso L.

Cancer Immun. 2007 Dec 19;7:20.

PMID:
18088084
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Mesothelin targeted cancer immunotherapy.

Hassan R, Ho M.

Eur J Cancer. 2008 Jan;44(1):46-53. Epub 2007 Oct 22. Review.

PMID:
17945478
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.

Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, Vachani A, Kapoor V, Sun J, Hodinka R, Brown JL, Corbley MJ, Parr M, Ho M, Pastan I, Machuzak M, Benedict W, Zhang XQ, Lord EM, Litzky LA, Heitjan DF, June CH, Kaiser LR, Vonderheide RH, Albelda SM, Kanther M.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4456-66. Erratum in: Clin Cancer Res. 2007 Sep 1;13(17):5226. Kanther, Michelle [added].

PMID:
17671130
[PubMed - indexed for MEDLINE]
Free Article
9.

Mesothelin expression in human lung cancer.

Ho M, Bera TK, Willingham MC, Onda M, Hassan R, FitzGerald D, Pastan I.

Clin Cancer Res. 2007 Mar 1;13(5):1571-5.

PMID:
17332303
[PubMed - indexed for MEDLINE]
Free Article
10.

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.

Gubbels JA, Belisle J, Onda M, Rancourt C, Migneault M, Ho M, Bera TK, Connor J, Sathyanarayana BK, Lee B, Pastan I, Patankar MS.

Mol Cancer. 2006 Oct 26;5(1):50.

PMID:
17067392
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Mesothelin is shed from tumor cells.

Ho M, Onda M, Wang QC, Hassan R, Pastan I, Lively MO.

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1751. No abstract available.

PMID:
16985043
[PubMed - indexed for MEDLINE]
Free Article
12.

Immunotoxin therapy of cancer.

Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ.

Nat Rev Cancer. 2006 Jul;6(7):559-65. Review.

PMID:
16794638
[PubMed - indexed for MEDLINE]
13.

Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.

Ho M, Nagata S, Pastan I.

Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9637-42. Epub 2006 Jun 8. Erratum in: Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14543.

PMID:
16763048
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Mesothelin variant 1 is released from tumor cells as a diagnostic marker.

Hellstrom I, Raycraft J, Kanan S, Sardesai NY, Verch T, Yang Y, Hellstrom KE.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1014-20.

PMID:
16702385
[PubMed - indexed for MEDLINE]
Free Article
15.

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

Scholler N, Garvik B, Hayden-Ledbetter M, Kline T, Urban N.

Cancer Lett. 2007 Mar 8;247(1):130-6. Epub 2006 May 4.

PMID:
16677756
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.

Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I.

Clin Cancer Res. 2005 May 15;11(10):3814-20.

PMID:
15897581
[PubMed - indexed for MEDLINE]
Free Article
17.

In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin.

Ho M, Kreitman RJ, Onda M, Pastan I.

J Biol Chem. 2005 Jan 7;280(1):607-17. Epub 2004 Oct 18.

PMID:
15491997
[PubMed - indexed for MEDLINE]
Free Article
18.

Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16).

Maeda T, Inoue M, Koshiba S, Yabuki T, Aoki M, Nunokawa E, Seki E, Matsuda T, Motoda Y, Kobayashi A, Hiroyasu F, Shirouzu M, Terada T, Hayami N, Ishizuka Y, Shinya N, Tatsuguchi A, Yoshida M, Hirota H, Matsuo Y, Tani K, Arakawa T, Carninci P, Kawai J, Hayashizaki Y, Kigawa T, Yokoyama S.

J Biol Chem. 2004 Mar 26;279(13):13174-82. Epub 2004 Feb 4.

PMID:
14764598
[PubMed - indexed for MEDLINE]
Free Article
19.

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.

Rump A, Morikawa Y, Tanaka M, Minami S, Umesaki N, Takeuchi M, Miyajima A.

J Biol Chem. 2004 Mar 5;279(10):9190-8. Epub 2003 Dec 15.

PMID:
14676194
[PubMed - indexed for MEDLINE]
Free Article
20.

Application of mesothelin immunostaining in tumor diagnosis.

Ordóñez NG.

Am J Surg Pathol. 2003 Nov;27(11):1418-28.

PMID:
14576474
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk